Find out more about the latest news in cardiovascular research including the development of disease biomarkers and cardiomyocyte sensors in this round-up.
Researchers have developed a new nanoplasmonic biosensor device that precisely detects the presence of anticoagulants in blood samples.
The biotechnology company, AYOXXA Biosystems, have launched a low-volume beads-on-a-chip multiplex protein analysis system termed LUNARIS™. It is aimed to quantify soluble inflammation and immune response markers.
In this commentary, the authors discuss test materials and study designs of method transfer studies for biotechnology products.